New insights in the clinical understanding of behçet's disease

Yonsei Medical Journal

Volumn 53, Issue 1, 2012, Pages 35-42

  Cho, Sung Bin ^a   Cho, Suhyun ^a   Bang, Dongsik ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Animal model; Beh et's disease; Diagnosis; Epidemiology; Etiopathogenesis; New biologics

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; ETANERCEPT; FLUORODEOXYGLUCOSE F 18; INFLIXIMAB;

ARTICLE; BEHCET DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ACTIVITY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; POLLUTANT; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; STREPTOCOCCUS SANGUINIS;

ANIMALS; BEHCET SYNDROME; BIOLOGICAL THERAPY; DISEASE MODELS, ANIMAL; HUMANS; PREVALENCE; WORLD HEALTH;

EID: 84455203084     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.1.35     Document Type: Article

References (71)

1. Feigenbaum A. Description of Behçet's syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 1956;40: 355-7.
2. Behçet H. Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre am Auge, und an den Genitalien. Dermatol Wochenschr 1937;105:1152-7.
3. Behçet H. Some observations on the clinical picture of the so-called triple symptom complex. Dermatologica 1940;81:73-83.
4. Jensen T. Sur les ulcerations aphteuses de la muqueues de la bouche et de la peau genitale combiness avec les sumptomes oculaires (syndrome Behçet). Acta Derm Venereol 1941;22:64-79.
5. Sezer FN. The isolation of a virus as the cause of Behcet's diseases. Am J Ophthalmol 1953;36:301-15.
6. Bouzas A. The Adamantiades-Behçet's syndrome. Bull Soc Hellen Ophthalmol 1956;24:41.
7. Strachan RW, Wigzell FW. Polyarthritis in Behcet's multiple symptom complex. Ann Rheum Dis 1963;22:26-35.
8. Robinson HMJ, McCrumb FRJ. Comparative analysis of the mucocutaneous ocular syndromes: report of eleven cases and review of the literature. Arch Dermatol Syphil 1950;61:539.
9. Firestein GS, Gruber HE, Weisman MH, Zvaifler NJ, Barber J, O'Duffy JD. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease. Am J Med 1985;79:65-72.
10. Levine JA, O'Duffy JD. Pseudo- Behçet's syndrome-a description of twenty-three cases. In: Godeau P, Wechsler B, editors. Behçet's disease: Proceedings of the Sixth International Conference on Behçet's disease, held in Paries, France, June 30 to July 1, 1993. Amsterdam: Elsevier Science Publishers; 1993. p.295-8.
11. Lee S, Bang D, Lee ES, Sohn S. Behçet's disease: a guide to its clinical understanding. 1st ed. Berlin, Heidelberg, New York: Springer Verlag; 2001.
12. Lee S. Behçet's disease or Behçet's syndrome-considerations for the unified diagnosis related terminology. In: Bang D, Lee ES, Lee S, editors. Behçet's disease: Proceedings of the Ninth International Conference on Behçet's disease, held in Seoul, Korea, May 27-29, 2000. Seoul: Design Mecca; 2000. p.40-2.
13. Barnes CG. History and diagnosis. In: Yazici Y, Yazici H, editors. Behçet's syndrome. 1st ed. New York: Springer; 2010. p.7-33.
14. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213-20.
15. Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet's disease: from East to West. Clin Rheumatol 2010;29:823-33.
16. Bang D, Lee ES, Lee S. Behçet's disease. In: Eun HC, Kim SC, Lee WS, editors. Asian Skin and Skin Diseases: special book of the 22nd World Congress of Dermatology, held from May 24-29, 2011: in Seoul, Korea. Seoul: MEDrang Inc.; 2011. p.313-25.
17. Chung YL, Bang DS, Lee ES, Lee SN, Mok JW, Park KS. Behçet's disease: the first Mongolian case in literature showing HLA B51, MICA gene type*5/*6. Yonsei Med J 2003;44:935-8.
18. Liozon E, Roussin C, Puéchal X, Garou A, Valadier P, Périnet I, et al. Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Joint Bone Spine 2011;78:166-70.
19. Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behçet's disease in Iran: analysis of 6500 cases. Int J Rheum Dis 2010;13:367-73.
20. Yurdakul S, Yazici Y. Epidemiology of Behçet's syndrome and regional differences in disease expression. In: Yazici Y, Yazici H, editors. Behçet's syndrome. 1st ed. New York: Springer; 2010. p.35-52.
21. Tugal-Tutkun I. Behçet disease in the developing world. Int Ophthalmol Clin 2010;50:87-98.
22. Yazici Y, Yurdakul S, Yazici H. Behçet's syndrome. Curr Rheumatol Rep 2010;12:429-35.
23. Yurdakul S, Günaydin I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y, et al. The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988;15:820-2.
24. Yesudian PD, Edirisinghe DN, O'Mahony C. Behçet's disease. Int J STD AIDS 2007;18:221-7.
25. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
26. Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6.
27. Kim DK, Chang SN, Bang D, Lee ES, Lee S. Clinical analysis of 40 cases of childhood-onset Behçet's disease. Pediatr Dermatol 1994;11:95-101.
28. Sungur G, Hazirolan D, Hekimoglu E, Kasim R, Duman S. Late-onset Behçet's disease: demographic, clinical, and ocular features. Graefes Arch Clin Exp Ophthalmol 2010;248:1325-30.
29. Fietta P. Behçet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol 2005;23:S96-105.
30. Bang DS, Oh SH, Lee KH, Lee ES, Lee SN. Influence of sex on patients with Behçet's disease in Korea. J Korean Med Sci 2003; 18:231-5.
31. Bang D, Chun YS, Haam IB, Lee ES, Lee S. The influence of pregnancy on Behçet's disease. Yonsei Med J 1997;38:437-43.
32. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982;100:1455-8.
33. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease. Eur J Dermatol 2008;18:489-98.
34. Wallace GR, Niemczyk E. Genetics in ocular inflammation--basic principles. Ocul Immunol Inflamm 2011;19:10-8.
35. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010;42:698-702.
36. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 2010;42: 703-6.
37. Lew W, Chang JY, Jung JY, Bang D. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease. Br J Dermatol 2008;158:505-11.
38. Shim J, Lee ES, Park S, Bang D, Sohn S. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model. Cytotherapy 2011;13:835-47.
39. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, et al. Human alpha-enolase from endothelial cells as a target antigen of anfare ti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 2003;48:2025-35.
40. Lee J, Wu W, Lee H, Chang J, Bang D, Lee K. The cross-reactivity of anti humanα-enolase antibody in the sera of Behçet's disease patients to Streptococcus sanguis antigen. Korean J Invest Dermatol 2005;12:83-92.
41. Lee S, Bang D, Cho YH, Lee ES, Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease. Arch Dermatol Res 1996;288:179-83.
42. Sohn S, Lee ES, Bang D, Lee S. Behçet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 1998;8:21-3.
43. Sohn S, Bang D, Lee ES, Kwon HJ, Lee SI, Lee S. Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice. Br J Dermatol 2001;145:799-804.
44. Sim JH, Park MJ, Park S, Lee ES. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity. Br J Dermatol 2011;164:1285-91.
45. Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 2006;45:1461-5.
46. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17:586-99.
47. Criteria for diagnosis of Behc ̧et's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
48. Kurokawa MS, Yoshikawa H, Suzuki N. Behçet's disease. Semin Respir Crit Care Med 2004;25:557-68.
49. Oh SH, Han EC, Lee JH, Bang D. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease. Clin Exp Dermatol 2009;34:e208-12.
50. Cheon JH, Kim ES, Shin SJ, Kim TI, Lee KM, Kim SW, et al. Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol 2009;104:2492-9.
51. Denecke T, Staeck O, Amthauer H, Hänninen EL. PET/CT visualises inflammatory activity of pulmonary artery aneurysms in Behçet disease. Eur J Nucl Med Mol Imaging 2007;34:970.
52. Cho SB, Yun M, Lee JH, Kim J, Shim WH, Bang D. Detection of cardiovascular system involvement in Behçet's disease using fluorodeoxyglucose positron emission tomography. Semin Arthritis Rheum 2011;40:461-6.
53. Coskun B, Saral Y, Gödekmerdan A, Erden I, Coskun N. Activation markers in Behçet's disease. Skinmed 2005;4:282-6.
54. Han EC, Cho SB, Ahn KJ, Oh SH, Kim J, Kim DS, et al. Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: a Pilot Study. Ann Dermatol 2011;23:313-20.
55. Oh SH, Lee KY, Lee JH, Bang D. Clinical manifestations associated with high titer of anti-streptolysin O in Behcet's disease. Clin Rheumatol 2008;27:999-1003.
56. Bang D. Clinical spectrum of Behçet's disease. J Dermatol 2001;28:610-3.
57. Bang D. Treatment of Behçet's disease. Yonsei Med J 1997;38: 401-10.
58. Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behçet's disease. Curr Opin Pharmacol 2004;4:183-8.
59. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008;67:1656-62.
60. Hamuryudan V, Kötter I. Medical management of Behçet's syndrome. In: Yazici Y, Yazici H, editors. Behçet's syndrome. 1st ed. New York: Springer; 2010. p.317-38.
61. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005;50:297-350.
62. Pato E, Muñoz-Fernández S, Francisco F, Abad MA, Maese J, Ortiz A, et al. Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. Semin Arthritis Rheum 2011;40:314-23.
63. Al-Otaibi LM, Porter SR, Poate TW. Behçet's disease: a review. J Dent Res 2005;84:209-22.
64. Alexoudi I, Kapsimali V, Vaiopoulos A, Kanakis M, Vaiopoulos G. Evaluation of current therapeutic strategies in Behçet's disease. Clin Rheumatol 2011;30:157-63.
65. Alpsoy E, Akman A. Behçet's disease: an algorithmic approach to its treatment. Arch Dermatol Res 2009;301:693-702.
66. Gul A. Standard and novel therapeutic approaches to Behçet's disease. Drugs 2007;67:2013-22.
67. Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum 2011;41:61-70.
68. Cobo-Ibáñez T, del Carmen Ordóñez M, Muñoz-Fernández S, Madero-Prado R, Martín-Mola E. Do TNF-blockers reduce or induce uveitis? Rheumatology (Oxford) 2008;47:731-2.
69. Wendling D, Paccou J, Berthelot JM, Flipo RM, Guillaume-Czitrom S, Prati C, et al. New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases. Semin Arthritis Rheum 2011. [Epub ahead of print]
70. Kaneko F, Togashi A, Saito S, Sakuma H, Oyama N, Nakamura K, et al. Behçet's disease (Adamantiades-Behçet's disease). Clin Dev Immunol 2011;2011:681956.
71. Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine (Baltimore) 2011;90:125-32.